MedPath

Levonorgestrel/Ethinylestradiol

Generic Name
Levonorgestrel/Ethinylestradiol

A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

Phase 3
Completed
Conditions
Pregnancy Prevention
Interventions
First Posted Date
2009-10-16
Last Posted Date
2013-06-24
Lead Sponsor
Teva Women's Health
Target Recruit Count
3597
Registration Number
NCT00996580
Locations
🇺🇸

Teva Women's Health Research Investigational Site, Tacoma, Washington, United States

A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

Phase 2
Completed
Conditions
Breakthrough Bleeding
Interventions
First Posted Date
2006-11-01
Last Posted Date
2013-07-26
Lead Sponsor
Duramed Research
Target Recruit Count
567
Registration Number
NCT00394771
Locations
🇺🇸

Duramed Investigational Site, Williston, Vermont, United States

Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive

Phase 3
Completed
Conditions
Contraception
Interventions
First Posted Date
2005-09-20
Last Posted Date
2016-11-16
Lead Sponsor
Duramed Research
Target Recruit Count
2235
Registration Number
NCT00196326
Locations
🇺🇸

Duramed Investigational Site, Tacoma, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath